Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

NCT06684327 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Paget Disease, Extramammary
Rhabdomyosarcoma
Testicular Cancer
Penile Cancer
Urachal Cancer

Interventions

DRUG: Albumin-paclitaxel Injection

Sponsor

Fudan University